Key result
Cardiomyocyte Miro1 deletion cuts mitochondrial transfer to fibroblasts by an absolute ~21% in mice.
Why the study?
Intercellular mitochondria transfer contributes to tissue homeostasis across several organs, but whether this process occurs in the heart and regulates cardiac function remained unclear.
Does Miro1-dependent intercellular mitochondria transfer from cardiomyocytes to cardiac fibroblasts prevent profibrotic fibroblast activation and maintain cardiac homeostasis in mouse and human preclinical models?
Does Miro1-dependent intercellular mitochondria transfer from cardiomyocytes to cardiac fibroblasts prevent profibrotic fibroblast activation and maintain cardiac homeostasis in mouse and human preclinical models?
This preclinical study identifies Miro1-dependent mitochondria transfer from cardiomyocytes to fibroblasts as a critical metabolic brake on cardiac fibrosis via SDHA enhancement, succinate reduction, and HIF1α inhibition, suggesting mitochondrial transplantation as a potential antifibrotic therapy.
Answers are grounded in this paper and cite their sources.
Miro1-mediated mitochondria transfer may limit cardiac fibrosis in mice; extends intercellular transfer to heart but leaves human relevance open.
Recent evidence indicates that mitochondria can move beyond their cell of origin and be internalized by neighboring cells, where they modulate cellular metabolism to influence cell fate. This process, termed intercellular mitochondria transfer, has recently been shown to contribute to tissue homeostasis across several organs. However, whether intercellular mitochondria transfer occurs in the heart and regulates its function remains unclear. Here, we identify intercellular mitochondria transfer from cardiomyocyte to cardiac fibroblasts as a critical regulator of heart homeostasis. Using complementary in vivo and in vitro approaches, we showed that cardiomyocytes transfer their mitochondria to cardiac fibroblasts through a Miro1-dependent mechanism and that this process prevents the profibrogenic activation of recipient fibroblasts under homeostatic conditions. Consistent with this finding, cardiomyocyte-specific Miro1 loss-of-function resulted in excessive cardiac fibrosis and impaired contractile function. Mechanistically, mitochondria transfer decreased succinate levels in recipient fibroblasts by enhancing SDHA expression and mitochondrial complex II activity, thereby inhibiting HIF1α-mediated profibrotic signaling. Finally, intravenous administration of isolated cardiomyocyte-derived mitochondria partially reversed fibroblast activation in mice with cardiomyocyte-specific Miro1 deficiency, further supporting the physiological relevance of mitochondria transfer. Taken together, our study reveals a novel mechanism by which cardiomyocytes maintain heart homeostasis and opens new therapeutic avenues for preventing cardiac fibrosis, a hallmark of cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Rodriguez et al. (2026) studied Cardiac fibrosis and heart homeostasis. Cardiomyocyte-specific Miro1 deletion (CM-MitoGFP/Miro1KO) vs. Control wild-type Miro1 mice (CM-MitoGFP/Miro1WT) was evaluated on Proportion of cardiac fibroblasts containing cardiomyocyte-derived GFP-positive mitochondria. Cardiomyocyte-specific Miro1 deletion reduced mitochondria transfer to cardiac fibroblasts from 26.8% to 6.2% and increased fibroblast density from 20.2% to 31.2% in mice.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: